Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Front Cell Infect Microbiol ; 12: 855008, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-36132991

RESUMO

Background: Non-alcoholic fatty liver disease (NAFLD) is intricately linked to dysregulation of the gut-liver axis, and correlated with intestinal inflammation and barrier disruption. Objectives: To investigate the protective effects and possible molecular mechanism of Schisantherin A (Sin A) in a high-fat diet (HFD) induced NAFLD mouse model. Methods: HFD-fed NAFLD mice were treated with the vehicle and 80 mg/kg Sin A every day for 6 weeks. The gut permeability of the NAFLD mice was assessed by intestinal permeability assays in vivo and transepithelial electrical resistance (TEER) measurements in vitro were also used to evaluate the function of the gut barrier. TLR4 inhibitor was then used to investigate the impact of Sin A in the LPS- TLR4 signaling pathway. Alternatively, the composition of the microbiome was assessed using 16S rRNA amplification. Finally, the experiment of antibiotic treatment was performed to elucidate the roles of the gut microbiome mediating Sin A induced metabolic benefits in the NAFLD mice. Results: We found that Sin A potently ameliorated HFD-induced hepatic steatosis and inflammation, alleviated gut inflammation, and restored intestinal barrier function. We also observed that Sin A improved gut permeability and reduced the release of lipopolysaccharide (LPS) into circulation and further found that Sin A can suppress LPS-TLR4 signaling to protect against HFD-induced NAFLD. Sin A treatment altered the composition of the microbiome in NAFLD mice compared to vehicle controls. Conclusions: Sin A is an effective and safe hepatoprotective agent against HFD-induced NAFLD by partly ameliorating gut inflammation, restoring intestinal barrier function, and regulating intestinal microbiota composition.


Assuntos
Hepatopatia Gordurosa não Alcoólica , Animais , Antibacterianos/farmacologia , Ciclo-Octanos , Dioxóis , Inflamação/metabolismo , Lignanas , Lipopolissacarídeos/metabolismo , Fígado/metabolismo , Camundongos , Camundongos Endogâmicos C57BL , Hepatopatia Gordurosa não Alcoólica/tratamento farmacológico , Hepatopatia Gordurosa não Alcoólica/etiologia , Hepatopatia Gordurosa não Alcoólica/metabolismo , RNA Ribossômico 16S , Receptor 4 Toll-Like/metabolismo
2.
Arch Pharm Res ; 43(12): 1259-1275, 2020 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-33206346

RESUMO

Harmine is isolated from the seeds of the medicinal plant, Peganum harmala L., and has been used for thousands of years in the Middle East and China. Harmine has many pharmacological activities including anti-inflammatory, neuroprotective, antidiabetic, and antitumor activities. Moreover, harmine exhibits insecticidal, antiviral, and antibacterial effects. Harmine derivatives exhibit pharmacological effects similar to those of harmine, but with better antitumor activity and low neurotoxicity. Many studies have been conducted on the pharmacological activities of harmine and harmine derivatives. This article reviews the pharmacological effects and associated mechanisms of harmine. In addition, the structure-activity relationship of harmine derivatives has been summarized.


Assuntos
Anti-Inflamatórios/farmacologia , Antineoplásicos Fitogênicos/farmacologia , Harmina/farmacologia , Hipoglicemiantes/farmacologia , Fármacos Neuroprotetores/farmacologia , Peganum , Animais , Anti-Inflamatórios/isolamento & purificação , Anti-Inflamatórios/farmacocinética , Antineoplásicos Fitogênicos/isolamento & purificação , Antineoplásicos Fitogênicos/farmacocinética , Harmina/análogos & derivados , Harmina/isolamento & purificação , Harmina/farmacocinética , Humanos , Hipoglicemiantes/isolamento & purificação , Hipoglicemiantes/farmacocinética , Estrutura Molecular , Fármacos Neuroprotetores/isolamento & purificação , Fármacos Neuroprotetores/farmacocinética , Peganum/química , Sementes , Relação Estrutura-Atividade
3.
Life Sci ; 246: 117418, 2020 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-32057899

RESUMO

Nonalcoholic fatty liver disease (NAFLD), which is characterized by disruption of lipid homeostasis, has been the leading cause of chronic liver disease worldwide. However, currently there is no effective therapy for NAFLD. Consequently, it is extremely urgent to explore the specific and effective target functioned as lipids regulator during the pathological process of NAFLD for the drug development. Transcription factor EB (TFEB) plays a crucial role in the regulation of lipid homeostasis through linking autophagy to energy metabolism at the transcriptional level. In this review, we summarize the currently available information regarding the mediation of TFEB in lipid metabolism during the pathological process of NAFLD, and the specific regulatory mechanism of TFEB activity. We further recapitulate TFEB as a promising therapeutic target for NAFLD, primarily through the regulation of lipid homeostasis, energy metabolism as well as immune defense. A better understanding of these key issues will be helpful to promote the development of therapeutic agents which specifically target TFEB to halt or reverse the pathological progression of NAFLD.


Assuntos
Fatores de Transcrição de Zíper de Leucina e Hélice-Alça-Hélix Básicos/antagonistas & inibidores , Metabolismo dos Lipídeos , Hepatopatia Gordurosa não Alcoólica/tratamento farmacológico , Animais , Humanos , Metabolismo dos Lipídeos/efeitos dos fármacos , Hepatopatia Gordurosa não Alcoólica/metabolismo
4.
ACS Appl Mater Interfaces ; 7(48): 26367-73, 2015 Dec 09.
Artigo em Inglês | MEDLINE | ID: mdl-26580088

RESUMO

SnO2 is regarded as one of the most promising anodes via conversion-alloying mechanism for advanced lithium ion batteries. However, the sluggish conversion reaction severely degrades the reversible capacity, Coulombic efficiency and rate capability. In this paper, through constructing porous Ni/SnO2 composite electrode composed of homogeneously distributed SnO2 and Ni nanoparticles, the reaction kinetics of SnO2 is greatly enhanced, leading to full conversion reaction, superior cycling stability and improved rate capability. The uniformly distributed Ni nanoparticles provide a fast charge transport pathway for electrochemical reactions, and restrict the direct contact and aggregation of SnO2 nanoparticles during cycling. In the meantime, the void space among the nanoclusters increases the contact area between the electrolyte and active materials, and accommodates the huge volume change during cycling as well. The Ni/SnO2 composite electrode possesses a high reversible capacity of 820.5 mAh g(-1) at 1 A g(-1) up to 100 cycles. More impressively, large capacity of 841.9, 806.6, and 770.7 mAh g(-1) can still be maintained at high current densities of 2, 5, and 10 A g(-1) respectively. The results demonstrate that Ni/SnO2 is a high-performance anode for advanced lithium-ion batteries with high specific capacity, excellent rate capability, and cycling stability.

5.
Sci Rep ; 5: 11804, 2015 Jul 02.
Artigo em Inglês | MEDLINE | ID: mdl-26133276

RESUMO

Lithium-ion batteries (LIBs) are promising energy storage devices for portable electronics, electric vehicles, and power-grid applications. It is highly desirable yet challenging to develop a simple and scalable method for constructions of sustainable materials for fast and safe LIBs. Herein, we exploit a novel and scalable route to synthesize ultrathin nanobelts of anatase TiO2, which is resource abundant and is eligible for safe anodes in LIBs. The achieved ultrathin nanobelts demonstrate outstanding performances for lithium storage because of the unique nanoarchitecture and appropriate composition. Unlike conventional alkali-hydrothermal approaches to hydrogen titanates, the present room temperature alkaline-free wet chemistry strategy guarantees the ultrathin thickness for the resultant titanate nanobelts. The anatase TiO2 ultrathin nanobelts were achieved simply by a subsequent calcination in air. The synthesis route is convenient for metal decoration and also for fabricating thin films of one/three dimensional arrays on various substrates at low temperatures, in absence of any seed layers.

6.
Rev. bras. farmacogn ; 24(3): 282-287, May-Jun/2014. graf
Artigo em Inglês | LILACS | ID: lil-719454

RESUMO

The objective of this study was to produce artificial antigens for astragaloside IV that could be used to prepare antibodies against astragaloside IV screened in Radix astragali (Astragalus membranaceus (Fisch) Bunge, Fabaceae) and its preparations, using an indirect ELISA. Astragaloside IV was coupled to carrier proteins, bovine serum albumin and ovalbumin using the sodium periodate method and was then evaluated using SDS-PAGE, MALDI-TOF MS and animal immunizations. The coupling ratio of astragaloside IV to bovine serum albumin ratio was determined to be thirteen, and the indirect ELISA demonstrated that three groups of mice immunized with astragaloside IV-bovine serum albumin produced anti-astragaloside IV- bovine serum albumin-specific antibody, with a minimum serum titer of 1:9600. A method for synthesizing highly immunogenic astragaloside IV artificial antigens was successfully developed thus indicating its feasibility in the establishment of a fast immunoassay for astragaloside IV content determination in Radix astragali and its products.

7.
Acta Neurol Taiwan ; 23(3): 102-7, 2014 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-26077182

RESUMO

Infarcts of the territory of posterior cerebral artery (PCA) are common and their clinical presentations are well known. However, stroke in young adults originating at the PCA is relatively rare. We describe the case of a young female patient with right PCA infarcts that were probably caused by spontaneous arterial dissection. Dissection was successfully treated with intravenous recombinant tissue plasminogen activator. Herein, we discuss the mechanism, management, serial magnetic resonance angiography results, and functional outcome of treatment.


Assuntos
Infarto Cerebral/tratamento farmacológico , Artéria Cerebral Posterior/patologia , Acidente Vascular Cerebral/tratamento farmacológico , Terapia Trombolítica/métodos , Adulto , Infarto Cerebral/etiologia , Feminino , Humanos , Acidente Vascular Cerebral/etiologia
8.
Chang Gung Med J ; 33(5): 581-5, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-20979710

RESUMO

Phlebosclerotic colitis is a rare type of ischemic colitis caused by obstruction of the veins in the intestinal wall and adjacent mesentery, and is most commonly seen in the ascending colon. We report a 56-year-old woman presenting with intermittent abdominal pain and diarrhea for three years. She had a liver abscess and two episodes of pancreatitis during this time and experienced progressive body weight loss. Initial radiologic findings showed multiple tortuous threadlike calcifications in the region of the right side of the colon and transverse colon on plain abdominal radiographs and computed tomography images. A colonoscopy demonstrated brownish-black pigmentation on the right side of the colon with scattered hyperemic patches. The more distal along the colon, the more normal the color of the bowel appeared. Follow-up studies revealed calcifications not only alongside the colonic and mesenteric veins, but also extending into the superior and inferior mesenteric veins. These findings have not been reported previously. As noted in our patient, this disease entity may not be confined to the tributaries of the superior mesenteric vein. The entire colon may be involved in advanced disease.


Assuntos
Colite Isquêmica/patologia , Oclusão Vascular Mesentérica/complicações , Veias Mesentéricas/patologia , Colite Isquêmica/etiologia , Colo/irrigação sanguínea , Colo/patologia , Feminino , Humanos , Pessoa de Meia-Idade , Esclerose/complicações
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...